303 results
Page 4 of 16
6-K
EX-99.1
rzgr5ah7tcgyf9rttz1
12 Oct 22
Current report (foreign)
5:17pm
6-K
EX-99.1
jg5nahxz
26 Sep 22
Current report (foreign)
7:18am
6-K
EX-99.1
nzudmquye
16 Sep 22
Current report (foreign)
4:20pm
6-K
EX-99.1
6jy7h71iy0m3db9lj
12 Sep 22
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in European Union
4:13pm
6-K
EX-99.1
ufeeb3ofwy4e
1 Sep 22
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.1-Adapted Bivalent COVID-19 Vaccine Booster in European Union
5:38pm
6-K
EX-99.1
cv2x12vn
31 Aug 22
Current report (foreign)
5:08pm
6-K
EX-99.1
0gtvrc28imj9y70gyan
26 Aug 22
Pfizer and BioNTech Complete Submission to European Medicines Agency for Omicron BA.4/BA.5 Adapted Bivalent Vaccine
4:53pm
6-K
EX-99.1
oajneo
23 Aug 22
Pfizer and BioNTech Announce Updated COVID-19 Vaccine Data Supporting Efficacy in Children 6 Months through 4 Years of Age
8:56am
6-K
EX-99.1
p6k7b tau67sf
22 Aug 22
Current report (foreign)
5:23pm
6-K
EX-99.1
hq9dfi232i
8 Aug 22
Unaudited Interim Condensed Consolidated Financial Statements
7:17am
6-K
EX-99.1
3f4xma 0sc
8 Aug 22
BioNTech Announces Second Quarter Financial Results and Corporate Update
7:16am
6-K
EX-99.2
ewfc83tr br
8 Aug 22
BioNTech Announces Second Quarter Financial Results and Corporate Update
7:16am
6-K
EX-99.1
2ma1bxs caa
27 Jul 22
Pfizer and BioNTech Advance COVID-19 Vaccine Strategy With Study Start of Next-Generation Vaccine Candidate Based on Enhanced Spike Protein Design
6:55am
6-K
EX-99.1
odfp0d
19 Jul 22
Pfizer and BioNTech Complete Submission to European Medicines Agency for Omicron BA.1 Adapted Bivalent Vaccine Candidate
5:12pm
6-K
EX-99.1
4q39 p7wsmt5b
8 Jul 22
Current report (foreign)
5:36pm
6-K
EX-99.1
w8pf9xem e6b0jqoy0
8 Jul 22
Pfizer and BioNTech Announce U.S. FDA Approval of their COVID-19 Vaccine COMIRNATY® For Adolescents 12 through 15 Years of Age
5:23pm
6-K
EX-99.1
y5dov
29 Jun 22
Pfizer and BioNTech Announce New Agreement with U.S. Government to Provide Additional Doses of COVID-19 Vaccine
6:36pm
6-K
EX-99.1
a7g0cyav5
29 Jun 22
Current report (foreign)
6:27pm
6-K
EX-99.1
o70ybibhpmtm jgzmn86
27 Jun 22
Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine Candidates Demonstrate High Immune Response Against Omicron
7:25am
6-K
EX-99.1
g6y02q3reme70xcj5m
17 Jun 22
Pfizer-BioNTech COVID-19 Vaccine Receives FDA Emergency Use Authorization for Children 6 Months through 4 Years of Age
5:59pm